Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS:
Cash and Cash Equivalents, at Carrying Value	$ 25,088	$ 19,226
Accounts receivable, net of allowance for doubtful accounts of $XX and $3,396 at 2011 and 2010, respectively	201,322	184,774
Inventories, net	46,821	49,265
Prepaid Expense, Current	13,128	14,959
Income Taxes Receivable, Current	5,294	17,943
Other Assets, Current	12,215	10,740
TOTAL CURRENT ASSETS	303,868	296,907
Property, Plant and Equipment, Net	138,824	125,418
INTANGIBLES, net	10,949	8,721
GOODWILL	163,337	163,337
Deferred Tax Assets, Net, Noncurrent	4,452	13,224
Other Assets, Noncurrent	39,580	28,909
TOTAL ASSETS	661,010	636,516
CURRENT LIABILITIES:
Accounts payable	50,821	55,168
Accrued payroll and related costs	38,969	34,919
Taxes other than payroll and income	6,979	11,787
Unearned revenues	10,887	13,868
Income taxes payable	14,462	9,542
Other accrued expenses	13,657	15,226
TOTAL CURRENT LIABILITIES	135,775	140,510
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	267,002	234,033
DEFERRED COMPENSATION	38,014	28,112
Deferred Tax Liabilities, Noncurrent	(8,870)	(6,777)
Other Liabilities, Noncurrent	41,960	39,171
EQUITY:
Preference shares, EUR 0.02 par value; 6,000,000 shares authorized, none issued or outstanding	0	0
Common Stock, Value, Issued	1,203	1,233
Additional paid-in capital	0	0
Retained Earnings (Accumulated Deficit)	415,930	361,255
Accumulated Other Comprehensive Income (Loss), Net of Tax	(8,626)	(8,413)
Treasury shares (at cost), XX at 2011 and 4,218,726 at 2010	(245,184)	(171,845)
Total Core Laboratories N.V. shareholders' equity	163,323	182,230
Stockholders' Equity Attributable to Noncontrolling Interest	6,066	5,683
TOTAL EQUITY	169,389	187,913
TOTAL LIABILITIES AND EQUITY	$ 661,010	$ 636,516